Carl Goldfischer - Director, Epizyme, Inc

As of June 15, 2021


Carl Goldfischer Net Worth

  • Net worth is estimated to be at least $37.19M
  • Owns at least 3,385,951 units of Epizyme, Inc stock
  • Sold an estimated value of $33.28M in the last 8 years at Epizyme, Inc

Carl Goldfischer Trading

  • Largest purchase of shares was 555,555 units , worth over $5M on January 12, 2016
  • Largest sale of shares was 466,667 units , worth over $13.65M on February 12, 2014
  • In total has made about 15 transactions over 8 years
  • Usually trades in June, with the busiest year in 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Carl Goldfischer Mailing Address

  • Mailing address is 161 West 61st Street New York NY 10022 NY

Epizyme, Inc Executive Compensation

Name
Year
Salary
Bonus
Restricted Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Robert B. Bazemore Jr. 2020 $650,000 - $3,237,620 $4,103,853 $370,500 $96,369 $8,458,342
Robert B. Bazemore Jr. 2019 $592,937 - $1,105,393 $2,060,531 $409,127 $5,630 $4,173,618
Robert B. Bazemore Jr. 2018 $575,667 - - $2,748,939 $320,575 $5,690 $3,650,871
Paolo Tombesi 2020 $460,000 - $250,006 $750,730 $174,800 $48,198 $1,683,734
Paolo Tombesi 2019 $168,901 - $612,848 $1,173,669 $76,076 $146,971 $2,178,465
Matthew E. Ros 2020 $447,982 - $250,006 $750,730 $174,800 $11,271 $1,634,789
Matthew E. Ros 2019 $432,600 - $538,793 $899,137 $199,861 $11,598 $2,081,989
Matthew E. Ros 2018 $420,000 - - $1,099,576 $187,100 $12,214 $1,718,890
Dr. Shefali Agarwal 2020 $478,000 - $274,990 $825,799 $199,804 $7,154 $1,785,747
Dr. Shefali Agarwal 2019 $463,500 - $894,607 $1,255,325 $265,122 $8,652 $2,887,206
Dr. Shefali Agarwal 2018 $199,615 $125,000 - $1,472,846 $200,500 $1,648 $1,999,609
Jeffery L. Kutok, M.D., Ph.D. 2020 $337,500 $85,000 $374,996 $1,124,996 $134,663 $6,813 $2,063,968
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1571498/000119312521138283/d839557ddef14a.htm

Epizyme, Inc Insider Trading

  • The most recent transaction was 2,029 units sold on April 7, 2021 by Jeffery Kutok worth over $17.86K
  • In the last 8 years, insiders at Epizyme, Inc sold an estimated value of $153.26M and bought an estimated value of $343.59M
  • The most active traders are Robert Copeland, President Research and CSO,  David Mott, Director,  and Andrew Singer, EVP & CFO
  • Insider trading is most common in June, with the busiest year in 2014
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1